Should Britain fast-track human trials for AI-designed drugs, or is speed killing safety?
AI has already designed drug candidates in as little as 46 days — a process that once took years. But critics warn that racing from algorithm to human trial is a dangerous gamble with real lives.
Anoniem stemmen is mogelijk. Registreer voor een profiel en score.
